The Hypothalamic-Pituitary-Somatotropic (HPS) axis is a neuroendocrine cascade regulating growth, anabolism, and metabolic flexibility through pulsatile secretion of Growth hormone (GH) and its hepatic mediator IGF-1. This axis orchestrates muscle synthesis, bone remodeling, lipolysis, and glucose homeostasis, with secretion patterns tightly coupled to sleep, Exercise, and nutrient availability. Dysfunction contributes to metabolic syndrome, sarcopenia, osteoporosis, and impaired wound healing.
Think of the HPS-axis as a construction company's night shift foreman system. The Hypothalamus is the project manager who sends out the daily work order (GHRH — growth hormone releasing hormone) based on blueprints (nutrient status, sleep depth, Exercise signals). The anterior pituitary is the foreman who dispatches crews (pulses of GH) — not continuously, but in strategic waves, especially during the deep-sleep night shift when repair work happens best. These GH crews travel to the Liver (the materials warehouse), which manufactures IGF-1 (the actual construction materials — steel beams, concrete mix). IGF-1 does the heavy lifting: building muscle, reinforcing bones, even clearing old structures (lipolysis). But there's a feedback loop — when enough materials flood the site, the Liver and muscle send signals back saying "we have enough steel for now," which tells the Hypothalamus to slow the work orders. Insulin is like the union rep who can override the foreman when food arrives (postprandial GH suppression). Meanwhile, Ghrelin from the empty stomach is the hungry crew yelling "we need resources NOW" (pre-meal GH spike). If the foreman system breaks — chronic stress, sleep deprivation, insulin resistance — the night shift stops showing up, construction halts, and the building (your body) starts to crumble.
Hypothalamic regulation:
The Hypothalamus (specifically arcuate nucleus) releases GHRH in pulsatile fashion (every 2-3 hours), stimulated by Ghrelin (from gastric X/A cells), sleep (deep slow-wave stages 3-4), Exercise (via Lactate accumulation), hypoglycaemia, and Amino Acids (especially Arginine). Somatostatin (SRIF) from Hypothalamus provides tonic inhibition between pulses.
Pituitary secretion:
GHRH binds to Gs-coupled receptors on anterior pituitary somatotrophs → ↑cAMP → ↑PKA → transcription of GH gene → vesicular release of 22 kDa GH protein. Ghrelin binds GHS-R1a receptor → ↑intracellular Ca²⁺ → potentiates GH release. GH secretion peaks 60-90 minutes after sleep onset (coinciding with deep sleep), with secondary peaks after Exercise and during fasting.
GH direct actions:
IGF-1 mediated actions:
GH → Liver → transcription of IGF-1 gene (via JAK2-STAT5) → secretion of IGF-1 bound to IGF-binding proteins (IGFBPs). IGF-1 binds IGF-1 receptor (tyrosine kinase) on target tissues:
Negative feedback:
IGF-1 → Hypothalamus (↓GHRH, ↑somatostatin) + anterior pituitary (↓GH gene transcription). Free fatty acids from Lipolysis → ↑somatostatin. High Insulin (postprandial state) → direct inhibition of somatotrophs.
Age-related decline (somatopause):
After age 30, GH pulse amplitude declines ~14% per decade. IGF-1 levels drop from ~300 ng/mL (age 20) to ~150 ng/mL (age 60). Mechanisms: ↓GHRH neurons, ↑hypothalamic somatostatin tone, ↓GH receptor sensitivity, visceral adiposity (↑Free fatty acids → feedback inhibition).
Metabolic dysfunction cascade:
HPS-axis suppression is a hallmark of metabolic syndrome. Insulin resistance → chronic hyperinsulinaemia → tonic GH suppression → ↓Lipolysis → ↑visceral adiposity → ↑Free fatty acids → further ↓GH (vicious cycle). IGF-1 <150 ng/mL in middle-aged patients correlates with ↑risk of Type 2 Diabetes, CVD, and sarcopenia. This maps to the Selfish Brain concept: when the brain senses metabolic threat, it hijacks resources by suppressing anabolic axes.
Sleep deprivation pathology:
Loss of deep sleep (stages 3-4) → loss of nocturnal GH pulses → ↓overnight protein synthesis, ↓Lipolysis, ↓immune function (Growth hormone upregulates NK cells and Th1 responses). Even one night of sleep restriction reduces next-day GH secretion by 50%. Chronic sleep deprivation accelerates somatopause, contributing to obesity, muscle atrophy, and osteoporosis.
Musculoskeletal implications:
Low IGF-1 (<120 ng/mL) predicts sarcopenia risk (inability to activate Satellite cells for muscle repair), osteoporosis (inadequate osteoblastic activity), and delayed wound healing (collagen synthesis requires GH + IGF-1). Athletes with overtraining syndrome show suppressed GH despite high Exercise volume — indicative of HPA-axis dominance (Cortisol suppresses GHRH).
Immune connections:
Growth hormone and IGF-1 are immunomodulatory: stimulate thymic output of T cells, enhance NK cell cytotoxicity, promote M2 macrophages (tissue repair phenotype). GH-deficient states (whether pathological or functional via chronic stress) show ↓lymphocytes, ↑inflammatory cytokines (IL-6, TNF-α), and impaired resolution of inflammation. This connects to Metamodel 1 (stress axes) and Metamodel 3 (immune tolerance).
Intervention leverage points:
Clinical red flags: